imetelstat development code experimental anticancer first telomerase inhibitor enter clinical early phase trials various cancer chemically imetelstat synthetic conjugate consisting three parts thio phosphoramide oligonucleotide palmitoyl lipid pharmacological component telomerase inhibition palmitic acid moiety conjugated via phosphothioate linkage backbone antisense oligonucleotide telomere shortening lower cell viability observed inhibition telomerase activity vitro values ranged different pancreatic cell lines httpsenwikipediaorgwikiimetelstat